(Q44985232)
Statements
Improved outcome of N-butyldeoxygalactonojirimycin-mediated substrate reduction therapy in a mouse model of Sandhoff disease (English)
David Smith
Mylvaganam Jeyakumar
Terry D Butters
Mario Cortina Borja
scientific article